Literature DB >> 15545009

Central depletion of angiotensinogen is associated with elevated AT1 receptors in the SFO and PVN.

Sherry O Kasper1, Carlos M Ferrario, Detlev Ganten, Debra I Diz.   

Abstract

The brain renin-angiotensin system (RAS) is important in fluid balance and blood pressure regulation. In this study, we compared angiotensin (Ang) receptor density in the subfornical organ (SFO) and paraventricular nucleus (PVN) of a) brain angiotensinogen deficient rats (ASrAogen); b) those with high levels of brain Ang II [(mRen2)27]; c) Hannover Sprague Dawley (SD) rats at 48 and 68 wks of age. Since there was no difference between the two ages in any of the three strains, the data from the 48 and 68 wk time points were combined. There was a significantly higher level of AT1 receptors in the SFO and PVN of ASrAogen animals compared to both the SD and (mRen2)27 rats. This suggests that the brain RAS is important in regulating receptor density and that the differences may be explained by lower levels of the peptide locally. These higher levels of receptors suggest that the ASrAogen animals in adulthood and early aging would be more sensitive to either circulating or endogenous brain Ang II than the SD animals of similar age. In contrast, the similar receptor density in the (mRen2)27 and SD rats suggest that previous reports of reduced responses in the (mRen2)27 rats may result from differences in post receptor mechanisms such as intracellular signaling. Moreover, our data reveal that functional assessments are necessary in addition to receptor density levels to understand the consequences of long-term alterations in brain tissue peptides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545009     DOI: 10.1007/bf03033436

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  32 in total

1.  AT(1) receptors mediate excitatory inputs to rostral ventrolateral medulla pressor neurons from hypothalamus.

Authors:  T Tagawa; R A Dampney
Journal:  Hypertension       Date:  1999-12       Impact factor: 10.190

2.  Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen.

Authors:  M Schinke; O Baltatu; M Böhm; J Peters; W Rascher; G Bricca; A Lippoldt; D Ganten; M Bader
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 3.  Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27.

Authors:  M A Lee; M Böhm; M Paul; M Bader; U Ganten; D Ganten
Journal:  Am J Physiol       Date:  1996-06

Review 4.  Angiotensin peptides as neurotransmitters/neuromodulators in the dorsomedial medulla.

Authors:  Debra I Diz; Jewell A Jessup; Brian M Westwood; Susan M Bosch; Sherry Vinsant; Patricia E Gallagher; David B Averill
Journal:  Clin Exp Pharmacol Physiol       Date:  2002 May-Jun       Impact factor: 2.557

Review 5.  Are angiotensin receptor blockers neuroprotective?

Authors:  Christa Thöne-Reineke; Mathias Zimmermann; Christian Neumann; Maxim Krikov; Jun Li; Nadja Gerova; Thomas Unger
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

Review 6.  Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease.

Authors:  R M Touyz
Journal:  Braz J Med Biol Res       Date:  2004-07-20       Impact factor: 2.590

7.  Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury.

Authors:  Ikuyo Kusaka; Gen Kusaka; Changman Zhou; Mami Ishikawa; Anil Nanda; D Neil Granger; John H Zhang; Jiping Tang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-06       Impact factor: 4.733

8.  Contribution of the vagus nerve to angiotensin II binding sites in the canine medulla.

Authors:  D I Diz; K L Barnes; C M Ferrario
Journal:  Brain Res Bull       Date:  1986-10       Impact factor: 4.077

9.  Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats.

Authors:  P D Senanayake; A Moriguchi; H Kumagai; D Ganten; C M Ferrario; K B Brosnihan
Journal:  Peptides       Date:  1994       Impact factor: 3.750

10.  Angiotensin II actions in paraventricular nucleus: functional evidence for neurotransmitter role in efferents originating in subfornical organ.

Authors:  J S Bains; A Potyok; A V Ferguson
Journal:  Brain Res       Date:  1992-12-25       Impact factor: 3.252

View more
  7 in total

Review 1.  Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging.

Authors:  Debra I Diz
Journal:  Hypertension       Date:  2008-05-12       Impact factor: 10.190

Review 2.  Molecular evidence of tissue renin-angiotensin systems: a focus on the brain.

Authors:  Koji Sakai; Curt D Sigmund
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

3.  Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen.

Authors:  Amy C Arnold; Atsushi Sakima; Detlev Ganten; Carlos M Ferrario; Debra I Diz
Journal:  Hypertension       Date:  2008-03-17       Impact factor: 10.190

Review 4.  Brain renin-angiotensin system in the nexus of hypertension and aging.

Authors:  Amy C Arnold; Patricia E Gallagher; Debra I Diz
Journal:  Hypertens Res       Date:  2012-10-18       Impact factor: 3.872

5.  Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats.

Authors:  Debra I Diz; Maria Antonia Garcia-Espinosa; Patricia E Gallagher; Detlev Ganten; Carlos M Ferrario; David B Averill
Journal:  J Cardiovasc Pharmacol       Date:  2008-06       Impact factor: 3.105

Review 6.  The brain renin-angiotensin system and cardiovascular responses to stress: insights from transgenic rats with low brain angiotensinogen.

Authors:  Amy C Arnold; Atsushi Sakima; Sherry O Kasper; Sherry Vinsant; Maria Antonia Garcia-Espinosa; Debra I Diz
Journal:  J Appl Physiol (1985)       Date:  2012-09-13

Review 7.  Potential mechanisms of hypothalamic renin-angiotensin system activation by leptin and DOCA-salt for the control of resting metabolism.

Authors:  Sarah A Sapouckey; Guorui Deng; Curt D Sigmund; Justin L Grobe
Journal:  Physiol Genomics       Date:  2017-10-06       Impact factor: 3.107

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.